Literature DB >> 17634241

Role of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus.

Simone Giannecchini1, Mauro Pistello, Patrizia Isola, Donatella Matteucci, Paola Mazzetti, Giulia Freer, Mauro Bendinelli.   

Abstract

A more or less pronounced resistance to superinfection by a second strain of the infecting virus has been observed in many lentivirus-infected hosts. We used a chimeric feline immunodeficiency virus (FIV), designated FIVchi, containing a large part of the env gene of a clade B virus (strain M2) and all the rest of the genome of a clade A virus (a p34TF10 molecular clone of the Petaluma strain modified to grow in lymphoid cells), to gain insights into such resistance. FIVchi was infectious and moderately pathogenic for cats and in vitro exhibited the neutralization specificity of the env donor. The experiments performed were bidirectional, in that cats preinfected with either parental virus were challenged with FIVchi and vice versa. The preinfected animals were partially or completely protected relative to what was observed in naïve control animals, most likely due, at least in part, to the circumstance that in all the preinfecting/challenge virus combinations examined, the first and the second virus shared significant viral components. Based on the proportions of complete protection observed, the role of a strongly matched viral envelope appeared to be modest and possibly dependent on the time interval between the first and the second infection. Furthermore, complete protection and the presence of measurable neutralizing antibodies capable of blocking the second virus in vitro were not associated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634241      PMCID: PMC2045460          DOI: 10.1128/JVI.01064-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies.

Authors:  S Giannecchini; D Del Mauro; D Matteucci; M Bendinelli
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  Live attenuated HIV vaccines: a proposal for further research and development.

Authors:  J Mills; R Desrosiers; E Rud; N Almond
Journal:  AIDS Res Hum Retroviruses       Date:  2000-10-10       Impact factor: 2.205

Review 3.  The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.

Authors:  M Altfeld; E S Rosenberg
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

4.  Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route.

Authors:  Mary Jo Burkhard; Candace K Mathiason; Kevin O'Halloran; Edward A Hoover
Journal:  AIDS Res Hum Retroviruses       Date:  2002-02-10       Impact factor: 2.205

5.  During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.

Authors:  M Bendinelli; M Pistello; D Del Mauro; G Cammarota; F Maggi; A Leonildi; S Giannecchini; C Bergamini; D Matteucci
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.

Authors:  E Khatissian; V Monceaux; M C Cumont; M P Kieny; A M Aubertin; B Hurtrel
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 7.  Mechanisms of protection against simian immunodeficiency virus infection.

Authors:  R Paul Johnson
Journal:  Vaccine       Date:  2002-05-06       Impact factor: 3.641

Review 8.  Prospects for vaccine protection against HIV-1 infection and AIDS.

Authors:  Norman L Letvin; Dan H Barouch; David C Montefiori
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

9.  Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence.

Authors:  Margaret J Hosie; Brian J Willett; Dieter Klein; Thomas H Dunsford; Celia Cannon; Masayuki Shimojima; James C Neil; Oswald Jarrett
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 10.  Vaccine protection against feline immunodeficiency virus: setting the challenge.

Authors:  M J Hosie; J A Beatty
Journal:  Aust Vet J       Date:  2007 Jan-Feb       Impact factor: 1.281

View more
  3 in total

1.  Reciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins.

Authors:  Zachary Klase; Kuan-Teh Jeang
Journal:  Virology       Date:  2013-06-05       Impact factor: 3.616

Review 2.  Feline immunodeficiency virus latency.

Authors:  Samantha J McDonnel; Ellen E Sparger; Brian G Murphy
Journal:  Retrovirology       Date:  2013-07-06       Impact factor: 4.602

3.  Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.

Authors:  Paweł M Bęczkowski; Matthew Harris; Navapon Techakriengkrai; Julia A Beatty; Brian J Willett; Margaret J Hosie
Journal:  Vaccine       Date:  2015-01-19       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.